Learning outcomes
By the end of this lesson you should be able to: describe phase I and phase II metabolism and give examples of each; explain the meaning of half-life and steady state; state the rule of thumb that steady state is reached after four to five half-lives; describe the kinetic difference between first-order and zero-order elimination and its clinical importance; explain how renal and hepatic impairment and aging change drug handling; and explain why some drugs have active metabolites.
Prerequisites
Lesson 3 (Absorption and distribution). Metabolism is the third of the four ADME stages and depends on the same membrane and distribution concepts.
The big idea
Metabolism makes a drug easier to excrete, because the kidney excretes water-soluble molecules and the liver excretes them into bile. What matters clinically is that this is not always the end of the story: some drugs are activated by metabolism (prodrugs), some form metabolites that are themselves active (and whose elimination becomes the limiting factor for the drug's duration), and some form metabolites that are toxic.
Phase I and phase II
| Phase | Reaction | Consequence | Examples |
|---|---|---|---|
| Phase I | Oxidation, reduction or hydrolysis, exposing a functional group | Makes the molecule more water-soluble and often changes its activity | The cytochrome P450 enzymes of the liver (CYP3A4, CYP2D6, CYP2C9), and alcohol dehydrogenase for ethanol |
| Phase II | Conjugation — glucuronidation, sulfation, acetylation, glycine conjugation | Produces a highly water-soluble and usually inactive molecule for excretion | Glucuronidation of morphine, acetylation of isoniazid, sulfation of paracetamol |
The cytochrome P450 system is the centre of this lesson because of what it does to other drugs. It is a family of enzymes whose synthesis can be increased (induced) by exposure to some drugs, and whose function can be blocked (inhibited) by others. Both actions change the plasma concentration of the second drug. One drug changes another drug's metabolism, and the interaction changes the dose that is needed.
| Interaction | Mechanism | Clinical examples |
|---|---|---|
| Induction | A drug increases the synthesis of CYP450, so the other drug is metabolised faster and its concentration falls | Rifampicin reduces the effectiveness of the oral contraceptive; carbamazepine, phenytoin and chronic alcohol intake do the same; dexamethasone is used to accelerate it |
| Inhibition | A drug blocks CYP450, so the other drug is metabolised slower and its concentration rises | Erythromycin and clarithromycin inhibit CYP3A4 and increase the toxicity of drugs like simvastatin and of carbamazepine; ketoconazole, cimetidine, amiodarone and fluconazole have similar effects; grapefruit juice inhibits CYP3A4 |
| Genetic variability | Individuals differ in their CYP enzymes, so the same dose produces different concentrations | CYP2D6 poor metabolisers have exaggerated responses to codeine and to some beta-blockers; ultra-rapid metabolisers fail to respond to codeine at all |
Watch outInduction is slow (days, because new enzyme must be synthesised) while inhibition is immediate, and induction persists for a comparable period after the inducing drug is stopped — which is why the oral contraceptive can fail for weeks after rifampicin is discontinued.
Worked example: half-life and steady state
At a constant rate of elimination the plasma concentration falls exponentially: after one half-life, half remains; after two, a quarter; after three, an eighth. This gives the most useful rule in prescribing: a drug reaches ninety-five per cent of its steady-state concentration after about four to five half-lives, and is effectively eliminated over the same interval. Everything about dosing interval and the delay before a drug becomes effective follows from this.
| Concept | Value | Practical consequence |
|---|---|---|
| Half-life of phenytoin | About 20 to 40 hours | It takes over a week to reach steady state and over a week to leave the system, which is why a low starting dose is essential |
| Half-life of digoxin | About 36 to 48 hours | Therapeutic effect requires days to emerge fully, so the loading dose accelerates onset |
| Half-life of amiodarone | Weeks | The drug persists for months after the last dose, which is why its dose is reduced and why monitoring continues |
| Half-life of codeine's active metabolite | About 2 to 4 hours | A short interval between doses, and a rapid onset and offset of analgesia |
The maintenance dose needed at steady state is determined by two parameters: the rate of elimination (clearance) and the target concentration. Clearance is reduced by liver disease, by kidney disease for renally cleared drugs, and by the drugs that inhibit the enzyme. That is why a small dose of digoxin is used in a patient with a low creatinine clearance and why the same dose in the same patient weeks later may be toxic.
Zero-order kinetics, the exception, occurs when the eliminating enzyme or transporter is saturated, and the rate becomes constant rather than proportional to concentration. Alcohol, paracetamol in overdose and phenytoin at high concentrations are the classic examples, and the clinical importance is that a small increase in dose can cause a large and disproportionate rise in concentration — the reason paracetamol is dangerous in overdose, and why phenytoin dose increases must be small.
Common mistakes
Watch outSaying metabolites are always inactive. Many are active: morphine 6-glucuronide is analgesic; diazepam's desmethyldiazepam is active and long-lived, so sedation accumulates; the active metabolite of the antiplatelet clopidogrel is an active metabolite whose formation depends on a CYP enzyme.
Watch outSaying inducing a drug metabolises it into something more toxic. Usually induction lowers the concentration of the drug and therefore the effect. The exceptions are the drugs whose metabolite is the active form, where induction increases the effect.
Watch outSaying steady state is reached in one half-life. It takes about four to five. This is why lithium takes a week after each dose change before the level can be interpreted, and why phenytoin must be introduced slowly.
Check your understanding
Why do patients taking rifampicin need a different contraceptive plan?
How many half-lives does a drug need to reach steady state, and how long does elimination take?
Why is paracetamol dangerous in overdose but rarely dangerous in therapeutic doses?
Multiple choice
A patient taking rifampicin for tuberculosis loses the effect of their oral contraceptive. What is the mechanism?
Approximately how many half-lives are needed to reach steady state after repeated dosing?
Which of these is a phase II conjugation reaction?
Why is paracetamol hepatotoxic in overdose but not at therapeutic doses?
Which is the correct description of zero-order elimination?
Summary and next
Metabolism in the liver converts drugs to more water-soluble molecules through phase I reactions, above all the cytochrome P450 enzymes, and phase II conjugations. Because the P450 system can be induced or inhibited by other drugs, changing one drug can change another's concentration, and genetic variation changes it further. Steady state after repeated dosing comes after four to five half-lives, and a drug persists for the same interval after stopping. Zero-order elimination appears when a pathway saturates, and then small dose increases produce large concentration rises.
Next: drug development, prescribing and safety — how a drug reaches a patient, how it is tested, and how its toxic effects are minimised.